Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
20–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with mild to moderate hypertension with office Diastolic Blood Pressure (DBP) 90-109 mmHg and/or Systolic Blood Pressure (SBP) 140-179 mmHg
All women of child-bearing potential must have negative urine pregnancy tests within a week prior to initiation of therapy
You may not be if
females who are pregnant or breast feeding
office DBP ≥ 110 mmHg or office SBP ≥ 180 mmHg
history of significant cardiovascular diseases which includes:
* acute myocardial infarction within six months or any ischemic heart disease requiring medication.
* cerebrovascular disease
history of significant renal diseases including:
* serum creatinine \> 3.0 mg/dl.
* creatinine clearance \< 30 ml/min.
severe biliary cirrhosis and cholestasis
refractory hypokalemia, hypercalcemia
history of autoimmune disease, collagen vascular disease, multiple drug allergies, bronchospastic disease or other malignancies requiring current medication
hepatic disease as indicated by any of the following:
* SGOT or SGPT \>3 x upper limit of normal.
* Serum bilirubin \> 2 x upper limit of normal.
any other condition or therapy that, in the investigator's opinion, or as indicated in the product(s) label may pose a risk to the patient or interfere with the study objectives.
any other investigational drug given within 30 days of initiation of therapy, and participation in other clinical studies while enrolled in this protocol.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.